Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 223 entries
View as:

Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01065987 Org: User:
Start: 09/30/01 End: 11/30/01 Due: 11/30/02

Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT02296723 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01694797 Org: User:
Start: 01/31/11 End: 01/31/11 Due: 01/31/12

Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888718 Org: User:
Start: 02/28/11 End: 03/31/11 Due: 03/31/12

Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01146028 Org: User:
Start: 09/30/01 End: 11/30/01 Due: 11/30/02

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01159158 Org: User:
Start: 02/28/07 End: 02/28/07 Due: 02/28/08

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01511705 Org: User:
Start: 10/31/06 End: 10/31/06 Due: 10/31/07

Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01645423 Org: User:
Start: 08/31/09 End: 09/30/09 Due: 09/30/10

Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT01888263 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01161134 Org: User:
Start: 09/30/04 End: 11/30/04 Due: 11/30/05

Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01314352 Org: User:
Start: 12/31/05 End: 03/31/06 Due: 03/31/07

Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01052129 Org: User:
Start: 05/31/06 End: 05/31/06 Due: 05/31/07

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

Phase: N/A Priority: Normal
NCT ID: NCT01503424 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02922699 Org: User:
Start: 01/31/13 End: 06/30/13 Due: 06/30/14

Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01691456 Org: User:
Start: 01/31/11 End: 02/28/11 Due: 02/28/12

Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01136525 Org: User:
Start: 02/28/07 End: 05/31/07 Due: 05/31/08

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01164761 Org: User:
Start: 09/30/05 End: 10/31/05 Due: 10/31/06

Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01270308 Org: User:
Start: 12/31/08 End: 12/31/08 Due: 12/31/09

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01132352 Org: User:
Start: 09/30/03 End: 11/30/03 Due: 11/30/04

Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01131767 Org: User:
Start: 07/31/04 End: 09/30/04 Due: 09/30/05

Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT01674504 Org: User:
Start: 01/31/10 End: 01/31/10 Due: 01/31/11

Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02322658 Org: User:
Start: 09/30/08 End: 10/31/08 Due: 10/31/09

Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01133470 Org: User:
Start: 02/28/07 End: 04/30/07 Due: 04/30/08

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition

Phase: N/A Priority: Normal
NCT ID: NCT02292069 Org: User:
Start: 09/30/11 End: 10/31/11 Due: 10/31/12

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01559545 Org: User:
Start: 03/31/12 End: 03/31/13 Due: 03/31/14